Gary Lawrence 
FDA’s Expedited Drug Programs [PDF ebook] 
Analysis, Postmarket Monitoring and Industry Guidance

Sokongan

The Food and Drug Administration (FDA) oversees the safety and effectiveness of drugs sold on the U.S. market. When there is an unmet need for the treatment of a serious condition, FDA may use one or more of its expedited programs, such as fast track and breakthrough therapy designation, which are intended to bring drugs to market more quickly. FDA is also responsible for monitoring the safety of drugs and reporting on those efforts. This book examines the number and types of requests for fast track or breakthrough therapy designation; the number and types of FDA-approved drug applications that used an expedited program; and the extent to which FDA’s data on tracked safety issues and postmarket studies allowed the agency to meet its reporting and oversight responsibilities.

€167.65
cara bayaran
Beli ebook ini dan dapatkan 1 lagi PERCUMA!
Format PDF ● Halaman-halaman 113 ● ISBN 9781634857734 ● Penyunting Gary Lawrence ● Penerbit Nova Science Publishers ● Diterbitkan 2016 ● Muat turun 3 kali ● Mata wang EUR ● ID 7227061 ● Salin perlindungan Adobe DRM
Memerlukan pembaca ebook yang mampu DRM

Lebih banyak ebook daripada pengarang yang sama / Penyunting

17,523 Ebooks dalam kategori ini